e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,078.52 +37.23 (+3.58%)

Official Closing Price Updated: 7:00 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Why Eli Lilly (LLY) Stock Is Up Today

January 21, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its...

Via StockStory

Topics Artificial Intelligence Supply Chain

Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine

January 21, 2026

In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the...

Via TokenRing AI

Topics Artificial Intelligence Economy Intellectual Property

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,...

Via MarketMinute

Topics Earnings Economy Government

NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗

January 16, 2026

Via Stocktwits

Eli Lilly Stock Report: Momentum, Earnings And Analyst Targets ↗

January 21, 2026

Eli Lilly's stock is experiencing short-term volatility due to its proximity to a 52-week high and upcoming earnings, amid strong analyst support and mixed technical indicators.

Via Talk Markets

Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

January 20, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years ↗

January 20, 2026

Via Benzinga

What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗

January 20, 2026

Despite a challenging year, the company has a lot to look forward to in the coming years.

Via The Motley Fool

Is Oral Wegovy a Game Changer for Novo Nordisk? ↗

January 20, 2026

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.

Via The Motley Fool

AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing

January 20, 2026

LONDON — January 20, 2026 — In a milestone moment for global capital markets, pharmaceutical giant AstraZeneca (NYSE: AZN) has officially filed its formal notice of voluntary withdrawal from the Nasdaq...

Via MarketMinute

Topics Regulatory Compliance

3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗

January 20, 2026

Via MarketBeat

Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗

January 19, 2026

And the share price appreciation could happen pretty soon.

Via The Motley Fool

Down 55%, Should You Buy the Dip on Pfizer? ↗

January 19, 2026

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?

Via The Motley Fool

Topics Intellectual Property

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

Topics ETFs

Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine

January 19, 2026

In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation...

Via TokenRing AI

Topics Artificial Intelligence

The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗

January 19, 2026

All three of these healthcare giants are leaders in their niches.

Via The Motley Fool

Topics Artificial Intelligence

The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins

January 19, 2026

As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin...

Via Finterra

Topics Economy

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

January 19, 2026

As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its...

Via Finterra

Topics Artificial Intelligence Bankruptcy Economy

Prediction: 2026 Will Be the Year of Eli Lilly ↗

January 19, 2026

A catalyst lies just ahead.

Via The Motley Fool

Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗

January 18, 2026

Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets.

Via The Motley Fool

This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗

January 18, 2026

The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it.

Via The Motley Fool

Topics ETFs Economy

Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗

January 17, 2026

The pharmaceutical leader has plenty of cash and is using it effectively.

Via The Motley Fool

Topics Intellectual Property

Why a $6 Million Allocation to Short-Dated Credit Stands Out Right Now ↗

January 17, 2026

The Invesco BulletShares 2026 Corporate Bond ETF targets investment grade U.S. corporate bonds maturing in 2026 with a defined maturity profile.

Via The Motley Fool

Topics Bonds ETFs Regulatory Compliance

This Company Is Doubling Down on AI. Is the Stock a Buy? ↗

January 16, 2026

The pharmaceutical leader continues to grab headlines.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly: A Strong Player in the Pharmaceutical Arena ↗

January 16, 2026

Join us as we explore Eli Lilly's impressive market position and financial health. Discover why this pharmaceutical giant is capturing investor attention and what the future may hold for its stock.

Via The Motley Fool

The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine

January 16, 2026

In a milestone that many researchers are calling the "biological equivalent of the moon landing," AlphaFold 3 has officially moved structural biology into a new era of predictive precision. Developed...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗

January 16, 2026

The choice isn't that hard.

Via The Motley Fool

The $5.1 Trillion Wave: Why 2026 is Set to Become the Biggest Year for Global M&A

January 16, 2026

As the global economy shakes off the final remnants of the high-interest-rate era, a massive wave of consolidation is sweeping through corporate boardrooms. Analysts have officially adjusted their...

Via MarketMinute

Topics Artificial Intelligence Economy

Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. ↗

January 16, 2026

The high-powered duo is teaming up to build and equip a $1 billion research facility in California.

Via The Motley Fool

Topics Artificial Intelligence

Tema ETFs Adds $8 Million to an Industrial Stock Up 63% This Past Year ↗

January 16, 2026

Powell Industries designs and manufactures custom electrical systems for critical infrastructure in heavy industry and utilities worldwide.

Via The Motley Fool

Topics ETFs Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy